Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Mayo Clinic
National Cancer Institute, Egypt
Acepodia Biotech, Inc.
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)